Lidocaine %2 ampoule

Phase 3Small molecule

YYAARA TABIB

Lidocaine %2 ampoule is one of 57 small molecule programs targeting Lidocaine Infusion. It is currently in Phase 3.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Lidocaine InfusionNot yet recruiting

Neck PainActive, not recruiting

Colorectal CancerActive, not recruiting

Lidocaine InfusionPreclinical

Not yet recruiting

Neck PainPreclinical

Active, not recruiting

Colorectal CancerPreclinical

Active, not recruiting

Competition

Competitive Landscape

268 competitors in Colorectal Cancer

#DrugCompanyPhaseTrials

Stivarga

Bayer

Phase 3

39 2

Camptosar

Pfizer

Phase 3

34 3

Wellcovorin

EEastern Cooperative Oncology Group

Phase 3

58 4

Tyvyt

Innovent Biologics (Suzhou) Co. Ltd.

Phase 3

8 5

Trifluridine/tipiracil

AbbVie

Phase 3

3 6

Botensilimab

AAgenus Inc.

Phase 3

10 7

Balstilimab

AAgenus Inc.

Phase 3

10 8

Zanzalintinib

Merck & Co.

Phase 3

1 9

5-Fu

TToray Industries, Inc

Phase 3

3 10

Cadonilimab

SShanghai Pharmaceuticals Holding Co., Ltd

Phase 3

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q3 2027

Phase 3Not yet recruiting

Pain

NCT07792668

Q4 2027

Post-ApprovalNot yet recruiting

Agitation

NCT07268924

Q4 2028

Post-ApprovalNot yet recruiting

Randomized Controlled Trial

NCT07154628

Q4 2029

N/ANot yet recruiting

Lidocaine Infusion

NCT07318285

Clinical

Trials by Indication[1]

Agitation1 trial

The Effect of Propofol Versus Lidocaine on Emergence Agitation in Children Undergoing Tonsillectomy.

Not yet recruiting·—·Phase 4·NCT07268924·82 enrolled

Neck pain1 trial

Comparison of Mesotherapy Treatment Doses in Patients With Chronic Non-Specific Neck Pain

Completed·IIstanbul Medeniyet University·N/A·NCT07462988·80 enrolled

Lidocaine Infusion1 trial

Targeted Lidocaine Infusion for Pain Reduction in Office Hysteroscopy

Not yet recruiting·YYAARA TABIB·N/A·NCT07318285·208 enrolled

Intraocular Pressure1 trial

Effects Of Anaesthesia on Intraocular Pressure in Robotic Prostate Surgery

Completed·—·N/A·NCT07033442·60 enrolled

Anesthesia1 trial

Minimal Flow Anesthesia and Infection Risk

Active, not recruiting·—·N/A·NCT07092046·140 enrolled

11 more indications

Dexmedetomidine1 trial

Lidocaine, Paracetamol, and Dexmedetomidine for Rocuronium Injection Pain

Not yet recruiting·—·Phase 4·NCT07169227·170 enrolled

Intravitreal Injections1 trial

Study Evaluating the Efficacy and Safety of Chloroprocaine HCl Ophthalmic Gel 3% vs Proparacaine Ophthalmic Solution 0.5% Plus Subconjunctival Lidocaine in Patients Undergoing Intravitreal Injections

Not yet recruiting·HHarrow Inc·Phase 4·NCT07456826·236 enrolled

Colorectal Cancer1 trial

a Pilot Study of Lidocaine Infusion for Postoperative Analgesia in Elderly Patients With Colorectal Cancer Surgery

Completed·WWest China Hospital·N/A·NCT05412576·220 enrolled

Regional Anesthesia1 trial

Analgesic Efficacy of Two Doses of Dexmedetomidine as Adjuncts to Lidocaine for Intravenous Regional Anesthesia

Completed·—·Phase 4·NCT03399474·60 enrolled

Lidocaine1 trial

Lidocaine In-situ Gel Before Intrauterine Device Insertion

Completed·—·Phase 3·NCT02943135·120 enrolled

Sedation1 trial

Effect of IV Lidocaine on Duodenal Peristalsis and Sedation in ERCP

Recruiting·—·Phase 4·NCT07333859·120 enrolled

Tracheal Intubation1 trial

Comparison of Efficacy of Betamethasone Gel With Lidocaine Gel in Prevention of Post Endotracheal Intubation Sore Throat.

Not yet recruiting·JJinnah Postgraduate Medical Centre·Phase 1/2·NCT07256834·60 enrolled

Postoperative Analgesia1 trial

Comparing Efficacy of Intravenous Dexmedetomidine and Lidocaine on Postoperative Analgesia in Patients Undergoing Fracture Hip Surgery

Not yet recruiting·—·Phase 3·NCT06865469·56 enrolled

Gastric Bypass Surgery1 trial

Intraoperative Lidocaine Infusion as a Sole Analgesic Versus Morphine in Laparoscopic Gastric Bypass Surgery

Completed·—·Phase 1·NCT05150756·60 enrolled

Randomized Controlled Trial1 trial

Effect of Topical Lidocaine Spraying on the Vocal Cords Before Intubation During Robotic Surgery: a Randomized Controlled Trial

Not yet recruiting·KKaohsiung Medical University Chung-Ho Memorial Hospital·Phase 4·NCT07154628·80 enrolled

Pain1 trial

Comparison of No Premedication, Rectal Indomethacin Suppository, and Paracervical Block for Pain Reduction During Hysterosalpingography: A Prospective Randomized Three-Arm Controlled Trial

Not yet recruiting·BBalikesir University·Phase 3·NCT07792668·180 enrolled

Sources

References

[1]
ClinicalTrials.gov — 16 trial records for Lidocaine %2 ampoule. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Lidocaine %2 ampoule compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Lidocaine %2 ampoule. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — YAARA TABIB company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 3[1]
Company: YYAARA TABIB

Lidocaine %2 ampoule

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q3 2027

Q4 2027

Q4 2028

Q4 2029

Trials by Indication[1]

Agitation1 trial

Neck pain1 trial

Lidocaine Infusion1 trial

Intraocular Pressure1 trial

Anesthesia1 trial

Dexmedetomidine1 trial

Intravitreal Injections1 trial

Colorectal Cancer1 trial

Regional Anesthesia1 trial

Lidocaine1 trial

Sedation1 trial

Tracheal Intubation1 trial

Postoperative Analgesia1 trial

Gastric Bypass Surgery1 trial

Randomized Controlled Trial1 trial

Pain1 trial

References

Drug Info

Quick Facts

Related News